E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 11, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 309
- −23 vs. Q1 2023
- Portfolio value
- $1.26B
- −$105.4M (−7.7%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LCIDLucid Group, Inc. | COM | 14,095 | $97.0K | <0.1% | −2,208−13.5% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 10,524 | $95.0K | <0.1% | +10,524 | New | History |
| ALLKAllakos Inc. | COM | 18,996 | $83.0K | <0.1% | −2,454−11.4% | Reduced | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 11,832 | $78.0K | <0.1% | −1,228−9.4% | Reduced | History |
| BTAIQBioXcel Therapeutics, Inc. | COM | 10,628 | $71.0K | <0.1% | +10,628 | New | History |
| EQRXEQRx, Inc. | COM | 33,322 | $62.0K | <0.1% | −29,258−46.8% | Reduced | History |
| MRSNMersana Therapeutics, Inc. | COM | 18,105 | $60.0K | <0.1% | −9,473−34.3% | Reduced | History |
| LYELLyell Immunopharma, Inc. | COM | 17,491 | $56.0K | <0.1% | −11,247−39.1% | Reduced | History |
| KYNBKyntra Bio, Inc. | COM | 19,515 | $53.0K | <0.1% | +5,564+39.9% | Added | History |
Sold out since Q1 2023 (34)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| TCOMTrip.com Group Ltd | ADS | 511,252 | $19.3M | 1.4% | History |
| iShares Inc46434G855 | MSCI GBL GOLD MN | 159,850 | $4.02M | 0.3% | – |
| IAUiShares Gold Trust | ETF | 92,405 | $3.45M | 0.3% | History |
| GLDMWorld Gold Trust | SPDR GLD MINIS | 88,235 | $3.45M | 0.3% | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 87,434 | $2.83M | 0.2% | – |
| ZLABZai Lab Ltd | ADR | 82,587 | $2.75M | 0.2% | History |
| GLDSPDR Gold Trust | ETF | 14,210 | $2.60M | 0.2% | History |
| Dada Nexus Ltd23344D108 | ADS | 131,591 | $1.11M | 0.1% | – |
| FISVFiserv Inc | Stock | 6,778 | $766.0K | 0.1% | History |
| RXDXPrometheus Biosciences, Inc. | COM | 3,377 | $362.0K | <0.1% | History |
| CRDOCredo Technology Group Holding Ltd | Stock | 29,479 | $278.0K | <0.1% | History |
| CTICCti Biopharma Corp | COM | 64,520 | $271.0K | <0.1% | History |
| FSLRFirst Solar, Inc. | Stock | 1,071 | $233.0K | <0.1% | History |
| TEAMAtlassian Corp | CL A | 1,337 | $229.0K | <0.1% | History |
| TDYTeledyne Technologies Inc | COM | 507 | $227.0K | <0.1% | History |
| REPLReplimune Group, Inc. | COM | 12,305 | $217.0K | <0.1% | History |
| PLDPrologis, Inc. | REIT | 1,720 | $215.0K | <0.1% | History |
| MSMorgan Stanley | Stock | 2,434 | $214.0K | <0.1% | History |
| HUMHumana Inc | Stock | 435 | $211.0K | <0.1% | History |
| DEDeere & Co | Stock | 504 | $208.0K | <0.1% | History |
| GSGoldman Sachs Group Inc | Stock | 631 | $206.0K | <0.1% | History |
| SWKSSkyworks Solutions, Inc. | Stock | 1,717 | $203.0K | <0.1% | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 51,849 | $202.0K | <0.1% | History |
| XNCRXencor Inc | COM | 7,213 | $201.0K | <0.1% | History |
| LMTLockheed Martin Corp | Stock | 424 | $200.0K | <0.1% | History |
| CHRSCoherus Oncology, Inc. | COM | 22,741 | $156.0K | <0.1% | History |
| ALTAltimmune, Inc. | COM NEW | 29,334 | $124.0K | <0.1% | History |
| INOInovio Pharmaceuticals, Inc. | COM NEW | 129,289 | $106.0K | <0.1% | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 32,062 | $93.0K | <0.1% | History |
| ALECAlector, Inc. | COM | 14,089 | $87.0K | <0.1% | History |
| CRBUCaribou Biosciences, Inc. | COM | 13,274 | $70.0K | <0.1% | History |
| SGMOQSangamo Therapeutics, Inc | COM | 35,003 | $62.0K | <0.1% | History |
| STROSutro Biopharma, Inc. | COM | 12,245 | $57.0K | <0.1% | History |
| KZRKezar Life Sciences, Inc. | COM | 14,149 | $44.0K | <0.1% | History |